Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

Michael Jacobsen Biography and Net Worth

CAO of Omeros

Mr. Jacobsen joined Omeros in August 2013 as our vice president of finance and has served as our chief accounting officer and treasurer since October 2013. Prior to joining Omeros, Mr. Jacobsen served as vice president of finance at Sarepta Therapeutics from September 2011 to May 2013 and as its chief accounting officer from September 2011 to December 2012. From April 2007 to August 2011, Mr. Jacobsen was vice president and chief accounting officer at ZymoGenetics. Prior to his service with ZymoGenetics, Mr. Jacobsen held various roles at ICOS Corporation, including senior director of finance and corporate controller. From April 1995 to October 2001, Mr. Jacobsen held vice president of finance or chief financial officer roles at three companies in the software, computer hardware and internet retailing industries, two of which were publicly traded. Mr. Jacobsen is a certified public accountant and received his bachelor’s degree in accounting from Idaho State University.

What is Michael A. Jacobsen's net worth?: The estimated net worth of Michael A. Jacobsen is at least $77,040.00 as of February 22nd, 2021. Mr. Jacobsen owns 24,000 shares of Omeros stock worth more than $77,040 as of April 18th. This net worth evaluation does not reflect any other investments that Mr. Jacobsen may own. Additionally, Mr. Jacobsen receives an annual salary of $518,600.00 as CAO at Omeros. Learn More about Michael A. Jacobsen's net worth.
How old is Michael A. Jacobsen?: Mr. Jacobsen is currently 66 years old. There are 8 older executives and no younger executives at Omeros. The oldest executive at Omeros is Dr. George A. Gaitanaris M.D., Ph.D., Chief Scientific Officer & VP of Science, who is 67 years old. Learn More on Michael A. Jacobsen's age.
What is Michael A. Jacobsen's salary?: As the CAO of Omeros Co., Mr. Jacobsen earns $518,600.00 per year. The highest earning executive at Omeros is Dr. Gregory A. Demopulos M.D., Co-Founder, Chairman, CEO & President, who commands a salary of $1,790,000.00 per year. Learn More on Michael A. Jacobsen's salary.
How do I contact Michael A. Jacobsen?: The corporate mailing address for Mr. Jacobsen and other Omeros executives is 201 ELLIOT AVENUE WEST, SEATTLE WA, 98119. Omeros can also be reached via phone at (206) 676-5000 and via email at [email protected]. Learn More on Michael A. Jacobsen's contact information.
Has Michael A. Jacobsen been buying or selling shares of Omeros?: Michael A. Jacobsen has not been actively trading shares of Omeros during the last quarter. Most recently, Michael A. Jacobsen sold 8,100 shares of the business's stock in a transaction on Monday, February 22nd. The shares were sold at an average price of $23.28, for a transaction totalling $188,568.00. Following the completion of the sale, the chief accounting officer now directly owns 24,000 shares of the company's stock, valued at $558,720. Learn More on Michael A. Jacobsen's trading history.
Who are Omeros' active insiders?: Omeros' insider roster includes Gregory Demopulos (CEO), and Michael Jacobsen (CAO). Learn More on Omeros' active insiders.
Are insiders buying or selling shares of Omeros?: During the last year, Omeros insiders bought shares 2 times. They purchased a total of 25,000 shares worth more than $40,500.00. During the last year, insiders at the biopharmaceutical company sold shares 1 times. They sold a total of 5,000 shares worth more than $32,300.00. The most recent insider tranaction occured on November, 17th when CEO Gregory A Md Demopulos bought 15,000 shares worth more than $25,200.00. Insiders at Omeros own 10.9% of the company. Learn More about insider trades at Omeros.
Information on this page was last updated on 11/17/2023.

Michael A. Jacobsen Insider Trading History at Omeros

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/22/2021	Sell	8,100	$23.28	$188,568.00	24,000
2/19/2021	Sell	10,000	$22.64	$226,400.00	24,000
2/10/2021	Sell	1,900	$22.49	$42,731.00	15,900
1/19/2021	Sell	9,500	$19.95	$189,525.00	4,000
5/15/2018	Sell	23,792	$23.80	$566,249.60	19,480
1/3/2018	Sell	1,020	$22.45	$22,899.00	8,520
6/16/2017	Sell	12,000	$24.95	$299,400.00	19,500
6/15/2017	Sell	24,000	$21.20	$508,800.00	2,650

Michael A. Jacobsen Buying and Selling Activity at Omeros

Omeros Company Overview

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19. It also develops OMS1029 that is in phase I clinical trials for long-acting second-generation antibody targeting lectin pathway disorders; OMS906 that is in phase Ib clinical trials for Paroxysmal nocturnal hemoglobinuria, complement 3 glomerulopathy, and other alternative pathway disorders; OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders; and OMS405 that is in phase II clinical trials for opioid and nicotine addiction. In addition, the company develops MASP-2-small-molecule inhibitors for the treatment of aHUS, HSCT-TMA, and age-related macular degeneration; GPR174 inhibitors and chimeric antigen receptor T-Cell and adoptive T-Cell therapies for various cancers; and G protein-coupled receptors for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.

Today's Range

Now: $3.21

$3.20

$3.41

50 Day Range

MA: $3.90

$3.05

$4.89

2 Week Range

Now: $3.21

$0.92

$7.80

Volume

429,130 shs

Average Volume

568,299 shs

Market Capitalization

$185.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

Michael Jacobsen Biography and Net Worth

What is Michael A. Jacobsen's net worth?

How old is Michael A. Jacobsen?

What is Michael A. Jacobsen's salary?

How do I contact Michael A. Jacobsen?

Has Michael A. Jacobsen been buying or selling shares of Omeros?

Who are Omeros' active insiders?

Are insiders buying or selling shares of Omeros?